Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference

SAN DIEGO, June 5 Amylin Pharmaceuticals, Inc.(Nasdaq: AMLN) will be presenting at the Goldman Sachs Global HealthcareConference in Dana Point on Wednesday, June 11, 2008 at 1:20 p.m. PT. DanielM. Bradbury, President and Chief Executive Officer of Amylin Pharmaceuticals,will be providing a corporate overview.

The live presentation will be Web cast, and a recording will be madeavailable following the event. The Web cast and recording will be accessiblethrough Amylin's corporate Web site, located at http://www.amylin.com. Toaccess the live Web cast, please log on to Amylin's site approximately fifteenminutes prior to the presentation to register and download any necessary audiosoftware.

About Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company committed toimproving lives through the discovery, development and commercialization ofinnovative medicines. Amylin has developed and gained approval for twofirst-in-class medicines for diabetes, SYMLIN(R) (pramlintide acetate)injection and BYETTA(R) (exenatide) injection. Amylin's research anddevelopment activities leverage the company's expertise in metabolism todevelop potential therapies to treat diabetes and obesity. Amylin isheadquartered in San Diego, California with over 2,000 employees nationwide.Further information on Amylin Pharmaceuticals is available athttp://www.amylin.com.

SOURCE Amylin Pharmaceuticals, Inc.

Latest Press Release on General News

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...

A 2017 Hyundai Elantra and 760,000 kilometres of life-saving blood donation deliveries

Mr. Tim German's 2017 Hyundai Elantra a.k.a. "Dark Angel," was bought new from Steele Hyundai Halifax and now has more than 760,000 kilometres on the odometer. With his Elantra, Mr....

Philips Respironics Reaches Agreement with US Government on a Consent Decree Creating a Clear Path Forward

April 10, 2024 Philips confirms that further to communicating the main terms of the Philips Respironics consent decree on January 29, 2024, Philips’ subsidiaries Philips Holding USA ...